Work

Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study” [Gynecol. Oncol. 151 (2018) 18–23]

Year: 2018

Type: erratum

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2018.10.022

Authors: Alexander B. Olawaiye, James J. Java, Thomas C. Krivak, Michael Friedlander, David G. Mutch, Gretchen Glaser, Melissa Geller, David M. O'Malley, Robert M. Wenham, Roger B. Lee, Diane C. Bodurka, Thomas J. Herzog, Michael A. Bookman

Institutions: Magee-Womens Hospital, University of Pittsburgh Medical Center, Roswell Park Comprehensive Cancer Center, NRG Oncology, Western Pennsylvania Hospital, UNSW Sydney, Prince of Wales Hospital, Washington University in St. Louis, Carilion Clinic, University of Minnesota, University of Minnesota Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Moffitt Cancer Center, MultiCare Tacoma General Hospital, The University of Texas MD Anderson Cancer Center, University of Cincinnati

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: G2732236747, G4054617085, G5996839100

OpenAlex ID: W2897763894

Cites:

Cited by: 2

Related to: 10